Literature DB >> 565887

Solitary brainstem metastasis.

H D Weiss, E P Richardson.   

Abstract

Progressive cranial nerve palsies and long-tract signs without increased intracranial pressure developed in three patients. All had a history of cancer, but two had been in remission for more than 5 years and were thought to be cured of the malignancy. The patients were treated with cranial irradiation and glucocorticoids, following which one patient made a dramatic neurologic recovery. In each case, postmortem examination showed a brainstem metastasis with no metastatic lesions elsewhere in the nervous system. An occult metastasis should be considered when signs or symptoms suggest brainstem tumor in an adult.

Entities:  

Mesh:

Year:  1978        PMID: 565887     DOI: 10.1212/wnl.28.6.562

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Solitary brainstem metastasis: comparisons of X-ray computed tomography and magnetic resonance imaging to pathology.

Authors:  R K Simpson; D M Sirbasku; D S Baskin
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

2.  Metastasis to the midbrain. Report of two cases.

Authors:  T Tomita; N Wetzel
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

3.  Inferior red nucleus syndrome (Benedikt's syndrome) due to a single intramesencephalic metastasis from a prostatic carcinoma. Case report.

Authors:  N Loseke; J Retif; J Noterman; J Flament-Durand
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

4.  Brain stem tumours-diagnosis and surgical treatment.

Authors:  R Schönmayr; A L Agnoli
Journal:  Neurosurg Rev       Date:  1983       Impact factor: 3.042

5.  Central Nervous System Metastasis in Patients With Urothelial Carcinoma: Institutional Experience and a Comprehensive Review of the Literature.

Authors:  Leonidas N Diamantopoulos; Ali R Khaki; Guru P Sonpavde; Vyshak A Venur; Evan Y Yu; Jonathan L Wright; Petros Grivas
Journal:  Clin Genitourin Cancer       Date:  2019-12-05       Impact factor: 2.872

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.